Zydus claims to develop world’s first technology to improve patient compliance and outcome, targeting both diabetes and obesity.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| The Impact of GLP-1 Receptor Agonists (e.g., Semaglutide) on Obesity and Cardiovascular Outcomes | 1 | 14 | April 7, 2025 | |
| Drug Delivery through Smart Capsules | 5 | 18 | June 14, 2025 | |
| Vote: Which advanced drug delivery platform will revolutionize pharma in next 5 years? | 1 | 23 | June 9, 2025 | |
| Recently Approved Drugs-Tirzepatide | 2 | 12 | April 21, 2025 | |
| Medication Adherence | 4 | 24 | May 26, 2025 |